Tom McNicholas has written widely on many aspects of urinary disease. He is particularly in demand for teaching on benign prostatic disease and urinary symptoms. He has major interests in the management of prostate cancer, the treatment of urinary stone disease and in making common urological investigations (especially prostatic biopsy) both painless and safer.
He has written over 150 major scientific papers which can be reviewed in the bibliography. Most recently he has been lead author of the chapter on Benign Prostatic Disease in the latest addition of Campbell’s Urology. This 4 volume textbook is the “bible” for urology and is used by urological experts worldwide. He is one of only a small handful of British urologists to have been recognised in this way.




The Innovation in Urology day TOM MCNICHOLAS MARCH 10, 2016

TOM MCNICHOLAS MARCH 10, 2016 Each year the RSM Urology Section hosts a programme of scientific events with national and international speakers exploring issues of interest to urologists. The ‘Innovation in Urology’ day organised by Tom McNicholas and Rik Bryan and sponsored by The Urology Foundation (TUF) on Friday 26 February 2016 was aimed at illustrating current innovations, exploring the
Read More....
Comments

Urolift keeping sex alive-Sunday Times

Read More....
Comments

Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate

British Journal of Urology International paper underlines need for men with BPH to discuss “male orgasmic dysfunction” with their doctor prior to any treatment; UroLift® system shows ability to treat prostate symptoms while preserving sexual function PLEASANTON, CA, US -- NeoTract, Inc., today welcomes the publication of a paper in the British Journal of Urology International
Read More....
Comments

Prospective, Randomized, Multinational Study of Prostatic Urethral Lift Versus Transurethral Resection of the Prostate: 12-month Results from the BPH6 Study


Hot off the press! Published online in a major scientific Journal there is more evidence on the value of the Urolift treatment option for men's urinary symptoms, this time compared to the long standing "Gold standard" of TURP.
Even though we know that TURP is overkill for many men it is reassuring to see this first head to head study.
In this international trial, part held in the UK NHS, men
Read More....
Comments

Mens Health Week Q & A on prostate cancer

During the recent Men’s Health Week a patient support website (http://www.localcounsellingcentre.co.uk/counselling_news_blog.html#.U80M6LR4xUQ)  offered the public the chance to ask me questions about their condition (Most enquiries were related to  prostate cancer).Introduction: At LCC we are often consulted by men who have been diagnosed with prostate cancer and who are concerned.
Read More....
Comments
See Older Posts...